FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-t Cells.

Authors:
Galli E; Frioni F; Malara T; Attardi E; Bellesi S and 4 more

Journal:
Mediterr J Hematol Infect Dis

Publication Year: 2024

DOI:
10.4084/MJHID.2024.029

PMCID:
PMC10927208

PMID:
38468840

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Mediterr J Hematol Infect Dis

Abbreviation: Mediterr J Hematol Infect Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Hematology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A Case of Central Venous Catheter-Related <i>Candida parapsilosis</i> Fungemia Evolved to Dissemina…
Amabile E; Totaro M; Cappelli LV and 2 more (2024) - Transparency Score: 2/6
Antibody Response to Breakthrough SARS-CoV-2 Infection in "Booster" Vaccinated Patients with Multip…
Sgherza N; Mestice A; Larocca AMV and 1 more (2024) - Transparency Score: 2/6
Clinical Characteristics and Treatment Response of a Novel ELANE Gene Mutation (c.295_303del) in Co…
Ning J. (2024) - Transparency Score: 2/6
Clinical Signs and Treatment of New-Onset Bone Marrow Failure Associated SARS-CoV-2 Infection in Ch…
Youssef MAM; Ahmed ES; Kamal DT and 4 more (2024) - Transparency Score: 2/6
Coexistence of Multiple Gene Variants in Some Patients with Erythrocytoses.
Benetti A; Bertozzi I; Ceolotto G and 5 more (2024) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests: The authors declare no conflict of Interest."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025